Monoclonal antibodies and its impact on modern health services- A review
DOI:
https://doi.org/10.7439/ijpr.v7i8.4296Keywords:
Free radical, Antioxidant, Ixora coccinea, DPPHAbstract
Recent developments in the ability to manipulate immunoglobulin genes has led to development of monoclonal antibodies directed against therapeutic targets. Nowadays, Monoclonal Antibodies act as useful therapies in case of diseases like Cancer, Autoimmune diseases, Infectious diseases and also in conditions like Transplant rejections. The dream of Monoclonal antibodies has been achieved due to advent of Hybridoma technology in 1975. Monoclonal antibodies are one of the most upcoming fields in biopharmaceutical sciences. The role they have played has brought a revolution in the sector of health services. Not only as a therapeutic tool, its roleplay has also touched the topics of analysis, purification, enrichment and also in mediation of physiological responses. Today, it is continuing to become a befitting reply to various notorious diseases, for which, health professionals had waited for a long time. The purpose of this manuscript is to bring forward , in brief, the role played by Monoclonal antibodies in health sector, various studies related to this marvellous therpeutic tool and the scope, it carries in the near future, and for many years to come.Downloads
Download data is not yet available.
Downloads
Published
2017-08-30
Issue
Section
Review Article
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Author must Submit Copyright form After acceptance of Article
How to Cite
1.
Das S, Sehgal VK. Monoclonal antibodies and its impact on modern health services- A review. Int J of Pharmc Res [Internet]. 2017 Aug. 30 [cited 2025 Mar. 14];7(8):154-9. Available from: https://ssjournals.co.in/index.php/ijpr/article/view/4296